SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 190.43-0.7%Feb 6 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: squetch who wrote (7359)9/23/1997 11:26:00 PM
From: Andrew H   of 32384
 
..Does this summary point #2 "normal range of glycemic control" mean nondiabetic normal? <<

As I read it, the answer to your first question would be yes, but it would probably be towards the limits of the range of what is now considered normal--from what Henry has been posting lately, it seems that those limits are being reevaluated and considered as something of a "pre-daibetic"category.

>>I mentioned the usage as a vitamin to Henry. I meant it in terms of broad range preventitive action. I personally am going to start paying much more attention to the side effects of Targretin and the others.<<

Not clear what you are talking about here--is it targretin? The usage of targretin as a vitamin? And just what is the connection of that (whatever it means and refers to) to your paying closer attention to the side effects? I can't follow where this is coming from. Must be tired or something.

Please clarify. Thanks.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext